Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/30/2025 | $173.00 | Buy → Hold | HSBC Securities |
| 9/18/2024 | $148.00 | Buy | HSBC Securities |
| 9/12/2024 | $130.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $153.00 | Buy | Redburn Atlantic |
| 1/4/2024 | $96.00 | Outperform | TD Cowen |
| 11/30/2023 | $91.00 → $94.00 | Outperform | Oppenheimer |
| 10/5/2023 | $75.00 | Outperform | Wolfe Research |
| 5/19/2023 | $69.00 | Buy | Citigroup |
S-8 - KKR & Co. Inc. (0001404912) (Filer)
10-K - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
The intelligent jobsite technology innovator secures record funding from KKR to expand data gathering and enrichment solutions. XOi, a leading provider of jobsite-focused technology solutions for the field service ecosystem, today announced the acquisition of Specifx, an on-demand data enrichment and metadata retrieval platform for field service equipment. The acquisition was enabled by an investment from funds managed by leading global investment firm KKR. The funding from KKR marks the most significant milestone yet in XOi's journey to build out its system of work for the field service ecosystem. This press release features multimedia. View the full release here: https://www.businesswi
KKR, a leading global investment firm, today announced the appointment of Guy Metcalfe as Senior Advisor. In his role, Mr. Metcalfe will leverage his extensive real estate and capital markets expertise and relationship network around the world to support KKR's global real estate investment activity, platform growth and other strategic initiatives. Mr. Metcalfe previously served as Managing Director at Morgan Stanley and led its real estate investment banking business for over two decades before retiring as Global Chairman in 2024. Over his more than 30-year career at Morgan Stanley, Mr. Metcalfe was involved in more than $850 billion in transactions across multiple geographies including n
KKR Continues to Be Committed to FUJI SOFT's Privatization; Will Not Withdraw its Second Tender Offer KKR, a leading global investment firm, announced today that in connection with the Second Tender Offer in its two-stage tender offer scheme (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED ("FUJI SOFT" or the "Company"; TSE stock code 9749) through FK Co., Ltd. (the "Offeror" or "FK Co."), an entity owned by investment funds managed by KKR, the Offeror has submitted an amendment statement to the Tender Offer Registration Statement that was submitted on November 20, 2024 (including the matters amended in the amendment statement to the Tender Offer Regi
KKR, a leading global investment firm, and Family Doctor Pty Ltd. ("Family Doctor"), a leading group of general practitioner ("GP") clinics in Australia, today announced a bespoke financing solution by KKR (through funds managed by KKR) to Family Doctor. KKR's bespoke financing solution positions the Family Doctor to accelerate its growth and expansion, including through acquisitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250302805504/en/ Founded in 2008, Family Doctor provides comprehensive medical care services through its network of more than 110 GP-run clinics located in key metropolitan and regional areas across Au
PHILADELPHIA and NEW YORK, Feb. 26, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2024, and that its board of directors has declared a first quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2024(1) Net investment income of $0.61 per share, compared to $0.77 per share for the quarter ended September 30, 2024Adjusted net investment income(2) of $0.66 per share, compared to $0.74 per share for th
KKR to be the largest and controlling shareholder KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; "HCG"), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR ("KKR") will become the largest shareholder in HCG and assume sole control of HCG's operations. Dr. BS Ajaikumar, Founder of HCG, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence. This press release features multimedia. View the full release here: https://www.businesswire.co
PHILADELPHIA and NEW YORK, Feb. 26, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2024, and that its board of directors has declared a first quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2024(1) Net investment income of $0.61 per share, compared to $0.77 per share for the quarter ended September 30, 2024Adjusted net investment income(2) of $0.66 per share, compared to $0.74 per share for th
KKR to be the largest and controlling shareholder KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; "HCG"), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR ("KKR") will become the largest shareholder in HCG and assume sole control of HCG's operations. Dr. BS Ajaikumar, Founder of HCG, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence. This press release features multimedia. View the full release here: https://www.businesswire.co
Transaction marks KKR's latest technology growth investment in Australia SEEK Growth Fund continues to be a material investor in the company KKR, a leading global investment firm, Employment Hero, a global leader in employment management solutions, and SEEK Investments, manager of the SEEK Growth Fund, a long-term investment fund focused on human capital management, today announced the signing of definitive agreements under which funds managed by KKR will acquire a stake in Employment Hero ("the Company") from SEEK Investments. The SEEK Growth Fund continues to be a material investor in Employment Hero. This press release features multimedia. View the full release here: https://www.busine
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $173.00
HSBC Securities initiated coverage of KKR with a rating of Buy and set a new price target of $148.00
Wells Fargo initiated coverage of KKR with a rating of Equal Weight and set a new price target of $130.00
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)